These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23801184)

  • 21. Prevalence of Candida species in different hospital wards and their susceptibility to antifungal agents: results of a three year survey.
    Fadda ME; Podda GS; Pisano MB; Deplano M; Cosentino S
    J Prev Med Hyg; 2008 Jun; 49(2):69-74. PubMed ID: 18847180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Candida rugosa, an emerging fungal pathogen with resistance to azoles: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program.
    Pfaller MA; Diekema DJ; Colombo AL; Kibbler C; Ng KP; Gibbs DL; Newell VA
    J Clin Microbiol; 2006 Oct; 44(10):3578-82. PubMed ID: 17021085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing.
    Pfaller MA; Diekema DJ; Gibbs DL; Newell VA; Meis JF; Gould IM; Fu W; Colombo AL; Rodriguez-Noriega E;
    J Clin Microbiol; 2007 Jun; 45(6):1735-45. PubMed ID: 17442797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Molecular epidemiologic surveillance and antifungal agent sensitivity of Candida albicans isolated from anesthesia intensive care units].
    Gülay Z; Ergon C; Ozkütük A; Yücesoy M; Biçmen M
    Mikrobiyol Bul; 2002; 36(3-4):309-16. PubMed ID: 12838665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antifungal susceptibility of Candida spp. isolates from blood cultures in a five-year period (1997-2001)].
    Durán MT; Velasco D; Canle D; Moure R; Villanueva R
    Enferm Infecc Microbiol Clin; 2003 Nov; 21(9):488-92. PubMed ID: 14572381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey.
    Pemán J; Cantón E; Quindós G; Eraso E; Alcoba J; Guinea J; Merino P; Ruiz-Pérez-de-Pipaon MT; Pérez-del-Molino L; Linares-Sicilia MJ; Marco F; García J; Roselló EM; Gómez-G-de-la-Pedrosa E; Borrell N; Porras A; Yagüe G;
    J Antimicrob Chemother; 2012 May; 67(5):1181-7. PubMed ID: 22351683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antifungal susceptibility and distribution of Candida spp. isolates from the University Hospital in the municipality of Dourados, State of Mato Grosso do Sul, Brazil.
    Almeida AA; Mesquita CS; Svidzinski TI; Oliveira KM
    Rev Soc Bras Med Trop; 2013; 46(3):335-9. PubMed ID: 23856873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Susceptibility patterns of Candida species recovered from Canadian intensive care units.
    Laverdiere M; Labbé AC; Restieri C; Rotstein C; Heyland D; Madger S; Stewart T
    J Crit Care; 2007 Sep; 22(3):245-50. PubMed ID: 17869976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disk diffusion test and E-test with enriched Mueller-Hinton agar for determining susceptibility of Candida species to voriconazole and fluconazole.
    Lee SC; Lo HJ; Fung CP; Lee N; See LC
    J Microbiol Immunol Infect; 2009 Apr; 42(2):148-53. PubMed ID: 19597647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital.
    Bedini A; Venturelli C; Mussini C; Guaraldi G; Codeluppi M; Borghi V; Rumpianesi F; Barchiesi F; Esposito R
    Clin Microbiol Infect; 2006 Jan; 12(1):75-80. PubMed ID: 16460550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activities of fluconazole and voriconazole against bloodstream isolates of Candida glabrata and Candida krusei: a 14-year study in a Spanish tertiary medical centre.
    Quindós G; Sánchez-Vargas LO; Villar-Vidal M; Eraso E; Alkorta M; Hernández-Almaraz JL
    Int J Antimicrob Agents; 2008 Mar; 31(3):266-71. PubMed ID: 18054468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Catheter-associated urinary tract infections in intensive care units at a university hospital in Turkey.
    Keten D; Aktas F; Guzel Tunccan O; Dizbay M; Kalkanci A; Biter G; Keten HS
    Bosn J Basic Med Sci; 2014 Nov; 14(4):227-33. PubMed ID: 25428675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Susceptibility to azoles and amphotericin B of isolates of Candida spp. Experience of a university health network, between 2004 and 2010].
    Porte L; León P; Gárate C; Guzmán AM; Labarca J; García P
    Rev Chilena Infectol; 2012 Apr; 29(2):149-55. PubMed ID: 22689028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Species distribution and drug susceptibilities of Candida isolates in TSARY 2010.
    Yang YL; Chen HT; Lin CC; Chu WL; Lo HJ;
    Diagn Microbiol Infect Dis; 2013 Jun; 76(2):182-6. PubMed ID: 23574935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antifungal use influences Candida species distribution and susceptibility in the intensive care unit.
    Fournier P; Schwebel C; Maubon D; Vesin A; Lebeau B; Foroni L; Hamidfar-Roy R; Cornet M; Timsit JF; Pelloux H
    J Antimicrob Chemother; 2011 Dec; 66(12):2880-6. PubMed ID: 21980066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral Candida isolates among HIV-infected subjects in Nigeria.
    Nweze EI; Ogbonnaya UL
    J Microbiol Immunol Infect; 2011 Jun; 44(3):172-7. PubMed ID: 21524610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [In vitro activity of fluconazole, voriconazole and posaconazole against Candida spp].
    Rubio Calvo MC; Gil J; Ramírez de Ocáriz I; Benito R; Rezusta A
    Rev Esp Quimioter; 2003 Jun; 16(2):227-32. PubMed ID: 12973462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of yeast other than Candida albicans in denture wearers.
    Cavaleiro I; Proença L; Félix S; Salema-Oom M
    J Prosthodont; 2013 Jul; 22(5):351-7. PubMed ID: 23289581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Candida blood stream infections observed between 2011 and 2016 in a large Italian University Hospital: A time-based retrospective analysis on epidemiology, biofilm production, antifungal agents consumption and drug-susceptibility.
    Brunetti G; Navazio AS; Giuliani A; Giordano A; Proli EM; Antonelli G; Raponi G
    PLoS One; 2019; 14(11):e0224678. PubMed ID: 31697722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Catheter-associated candiduria: Risk factors, medical interventions, and antifungal susceptibility.
    Padawer D; Pastukh N; Nitzan O; Labay K; Aharon I; Brodsky D; Glyatman T; Peretz A
    Am J Infect Control; 2015 Jul; 43(7):e19-22. PubMed ID: 25920705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.